TG Therapeutics Inc TGTX
$51.69 $1.43 (2.85%) 1D
Last Updated: Aug 19, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
TGTX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, TG Therapeutics Inc is classified as halal.
HALAL
Report Source: undefined Quarter Report
TG Therapeutics Inc. Stock Analysis TGTX
United States Health Care Mid Cap TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in Morrisville, North Carolina and currently employs 399 full-time employees. Its products include Ublituximab IV (anti-CD20 mAb), Ublituximab IV Simplified Dosing Schedule, Ublituximab Subcutaneous (anti-CD20 mAb), and Azer-cel. The company is engaged in late-stage clinical development of BRIUMVI. BRIUMVI is an anti-CD20 monoclonal antibody that can be administered to adults with relapsing forms of multiple sclerosis (RMS) in a one-hour infusion every 24 weeks, following the starting dose. The company is used for treatment of adults with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. The firm is also engaged in ULTIMATE I & II Trials Evaluating Single Agent Ublituximab in RMS. Its ENHANCE Phase 3b Trial is an ongoing, multi-center, open-label study designed to evaluate alternative dosing regimens for BRIUMVI in patients with RMS.
TG Therapeutics Inc (TGTX) Chart
Financial Metrics & Statements of TG Therapeutics Inc (TGTX)
FAQ's for TG Therapeutics Inc (TGTX)
- As of August 2026, TG Therapeutics Inc TGTX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TG Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in TG Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of TG Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of TG Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of TG Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to TG Therapeutics Inc (TGTX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
